#United States #San Diego #LifeSignals #UbiqVue #UltraLinQ

LifeSignals and UltraLinQ Unveil UbiqVue Holter System

LifeSignals, Inc. has proudly announced the launch of its innovative UbiqVue 2AYe Holter System during Heart Rhythm 2025, held at Booth #943 in San Diego. This new system, developed in collaboration with UltraLinQ Healthcare Solutions, promises to revolutionize the cardiac monitoring process by drastically improving turnaround times for diagnostic reports.

The UbiqVue Holter System, designed for ultimate efficiency, features a single-use, two-channel wearable biosensor that can capture essential ECG and event data for up to five days. This compact device is intended to simplify the management of patient data while enhancing accuracy and efficiency. Instead of taking days, the UbiqVue system ensures that Holter reports are available within hours, streamlining workflows for healthcare professionals.

At the heart of the system is the 2AYe Biosensor, a chest-worn device that continuously collects vital information during the monitoring period. The data collected is securely transmitted via a patient-facing app to a robust cloud-based system, ensuring that sensitive information remains protected and confidential. As soon as the Holter test is finished, the data undergoes automatic processing using cloud-based ECG analytics. This minimizes the need for extensive revisions by certified cardiac technicians and enables physicians to receive completed reports much faster than traditional methods.

One of the standout features of the UbiqVue Holter System is its disposable nature, which allows clinicians to easily distribute the device and for patients to apply it at home without complicated setups. The automatic connectivity to the app simplifies its use further, and there is no need for device returns, eliminating cumbersome logistics that often burden clinics and care teams.

Surendar Magar, the Co-Founder and CEO of LifeSignals, stated, "The UbiqVue Holter is the first Holter system specifically designed for the digital age. It removes workflow complexities and cost barriers, turning our vision of remote patient monitoring—whether in hospitals or at home—into a feasible reality for population health management." This sentiment underscores LifeSignals' commitment to providing high-quality, accessible healthcare solutions.

Theo Vouniseas, the Head of Finance and Operations at UltraLinQ, added, "For over 15 years, UltraLinQ has worked tirelessly to equip cardiologists with specialized tools and support aimed at optimizing workflows and improving diagnostic accuracy. We are excited to showcase the UbiqVue Holter System at Heart Rhythm 2025 and believe that its ease of use, reliability, and scalability will meet and exceed our clients' expectations."

The UbiqVue Holter System will be publicly demonstrated at the Heart Rhythm 2025 event taking place at the San Diego Convention Center from April 25-27, 2025. Attendees are invited to visit Booth #943 for live demonstrations and detailed explanations of how this cutting-edge technology can enhance patient care and streamline cardiac monitoring practices.

For further information regarding the UbiqVue Holter System, interested parties can visit the official websites of LifeSignals and UltraLinQ. This collaboration marks a significant advancement in the field of cardiology, ensuring better patient outcomes through innovative technology.